A placebo-controlled study of Kava kava in generalized anxiety disorder.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/12131602
Conclusion of this study
Improvement was observed with both treatments but no differences were found in the principal analysis. Post-hoc analyses revealed significant differences based on baseline anxiety severity, whereby kava was superior on the SARA in low anxiety and placebo was superior on the HADS and SARA in high anxiety. Both treatments were well tolerated. Although kava was not superior to placebo, it would be premature to rule it out as efficacious in GAD.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study